Remission induction using alemtuzumab can permit chemotherapy-refractory chronic lymphocytic leukemia (CLL) patients to undergo allogeneic stem cell transplantation (Q33364316)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Remission induction using alemtuzumab can permit chemotherapy-refractory chronic lymphocytic leukemia (CLL) patients to undergo allogeneic stem cell transplantation |
scientific article |
Statements
1 reference
Remission induction using alemtuzumab can permit chemotherapy-refractory chronic lymphocytic leukemia (CLL) patients to undergo allogeneic stem cell transplantation (English)
1 reference
Dietger Niederwieser
1 reference
Eckhard Thiel
1 reference
Wolfgang Knauf
1 reference
Kathrin Rieger
1 reference
Wolfgang Blau
1 reference
Ute Hegenbart
1 reference
Ulrich Von Gruenhagen
1 reference
1 December 2004
1 reference
1 reference
45
1 reference
12
1 reference
2455-2458
1 reference
Identifiers
1 reference
1 reference